Bydureon Interactions
There are 373 drugs known to interact with Bydureon (exenatide), along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 15 are major, 355 are moderate, and 3 are minor.
- View all 373 medications that may interact with Bydureon
- View Bydureon alcohol/food interactions (2)
- View Bydureon disease interactions (4)
Most frequently checked interactions
View interaction reports for Bydureon (exenatide) and the medicines listed below.
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- Farxiga (dapagliflozin)
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- glimepiride
- hydrochlorothiazide
- Invokana (canagliflozin)
- Jardiance (empagliflozin)
- Lantus (insulin glargine)
- Lantus SoloStar (insulin glargine)
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- metformin
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- rosuvastatin
- simvastatin
- tramadol
- Trulicity (dulaglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Bydureon alcohol/food interactions
There are 2 alcohol/food interactions with Bydureon (exenatide).
Bydureon disease interactions
There are 4 disease interactions with Bydureon (exenatide) which include:
More about Bydureon (exenatide)
- Bydureon consumer information
- Compare alternatives
- Reviews (270)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.